查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1990537

切除術市場：2026-2032年全球預測（按適應症、手術方法、手術流程和最終用戶分類）

Colectomy Procedures Market by Indication, Surgical Approach, Procedure Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，切除術市場價值將達到 19.5 億美元，到 2026 年將成長到 20.5 億美元，到 2032 年將達到 28.6 億美元，複合年成長率為 5.57%。

主要市場統計數據
基準年 2025 19.5億美元
預計年份：2026年 20.5億美元
預測年份 2032 28.6億美元
複合年成長率 (%) 5.57%

對切除術護理的最新趨勢進行了權威概述，將臨床實踐的演變、新技術的引入和醫療保健決策的趨勢聯繫起來。

本執行摘要全面檢驗了切除術技術，整合了影響醫療實踐和採購的臨床趨勢、手術流程演變以及相關人員動態。分析說明探討外科技術進步、手術全期照護路徑和醫療設備創新如何與醫療服務提供者的工作流程和病患期望相交織，進而影響臨床醫師和組織層面的決策。

切除術治療正迎來一個關鍵的轉折點，這得益於微創技術、重新設計的手術流程以及以結果為導向的臨床實踐的發展。

切除術領域正經歷著一場變革，其驅動力來自技術進步、不斷完善的臨床指南以及對基於價值的治療結果日益成長的重視。微創手術透過改善器械和視覺化技術，以及更深入地融入以早期復健和減少資源消耗為優先的手術全期流程，不斷拓展其臨床應用範圍。這種臨床發展動能正推動機器人輔助切除術從小眾應用發展成為某些複雜切除術的首選方案，促使人們重新評估培訓課程和資本投資計畫。

美國近期關稅調整對切除術相關技術的籌資策略、供應鏈韌性和供應商關係產生了哪些影響？

在美國，近期關稅政策的調整為參與切除術相關手術器械、機器人平台和一次性醫療設備組件採購的相關人員帶來了更多複雜性。這些政策變化正在影響醫院系統和門診網路的採購週期、供應商合約策略和資本支出計劃。擁有集中採購團隊的醫療機構正優先考慮合約重新談判和總體擁有成本 (TCO) 評估，以減輕對採購的即時影響，同時確保臨床能夠獲得優先技術。

從細分觀點主導，將適應症、手術細節、手術方法和臨床環境與對醫療設備、訓練和臨床路徑的實際影響聯繫起來。

細分市場分析揭示了每種適應症、手術方法、手術類型和終端用戶環境的不同臨床和商業性路徑，每種路徑都會對技術應用和醫療服務產生獨特的影響。基於適應症，我們針對癌症、克隆氏症、憩室病和潰瘍性大腸炎進行了市場調查，這種分佈反映了臨床優先事項。腫瘤切除術需要遵循腫瘤學原則，並在適用情況下進行淋巴結清除。發炎性腸道疾病通常需要複雜的決策，以保留腸道長度並控制慢性發炎變化。同時，對於憩室病和急性併發症，快速控制病灶和減少併發症至關重要。

對美洲、歐洲、中東和非洲以及亞太地區的醫療保健發展、能力擴張和採購趨勢進行區域比較分析。

區域趨勢正對臨床實踐模式、報銷框架和醫療設備部署物流產生實際影響，在美洲、歐洲、中東和非洲以及亞太地區形成了各自獨特的格局。在美洲，私部門與綜合醫療系統競爭，推動對微創和機器人手術能力的投資，同時兼顧手術全期效率和病患體驗。該地區的醫療服務提供者經常參與集中採購諮詢和以價值為導向的試驗計畫，這些項目影響醫療設備的選擇和服務合約模式。

競爭優勢、一體化服務交付和實證商業模式如何重新定義整個切除術生態系統的企業策略。

切除術生態系統的企業級趨勢揭示了一個由產品差異化、服務模式和夥伴關係策略共同塑造的競爭格局。領先的醫療設備製造商正優先考慮系統整合、循證醫學證據產生以及以外科醫生為中心的支持，以實現產品差異化。這包括投資於模組化器械、最佳化工作流程的一次性產品以及支援手術全期計劃和結果追蹤的數位化能力。

為醫療服務提供者和相關人員提供切實可行的策略措施，以加快安全部署、控制成本，並使臨床結果與商業性框架保持一致。

行業領導者可以將觀察到的趨勢轉化為具體的舉措，使臨床品質與營運和商業性目標保持一致。首先，他們應優先投資於臨床醫生培訓項目，以加速微創和機器人輔助手術技術的安全應用，同時融入促進復原的原則，從而提高處理能力和患者療效。系統化的教學、模擬和基於能力的認證體係可以減少差異，並實現可預測的專案規模化。

結合臨床證據、相關人員訪談和對醫療設備效能的洞察，採用混合方法研究框架，可以得出平衡、可操作的結論。

本執行摘要的研究整合了同行評審的臨床文獻、指南、手術註冊資料、醫療設備技術文檔，以及對多個地區臨床和供應鏈領導者的訪談。研究採用混合方法，結合定性訪談和主題分析，以識別實踐中的障礙和促進因素；同時，對臨床證據和醫療設備特性進行系統性回顧，為它們對手術和培訓的影響提供技術背景。

整合臨床、營運和商業性需求，為醫療機構在不斷變化的切除術。

總之，切除術技術正處於一個策略性的十字路口，臨床創新、營運模式重塑和商業性動態在此交匯，為醫療服務提供者和產業夥伴帶來機會和挑戰。微創和機器人輔助手術技術持續推動臨床能力的提升，而市場和政策壓力則凸顯了採購中靈活且注重成本效益的部署策略的重要性。適應症特定要求、手術多樣性和最終用戶環境之間的相互作用，要求採用量身定做的方法，在滿足臨床細微差別的同時，實現可擴展的部署。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：切除術市場：依適應症分類

  • 癌症
  • 克隆氏症
  • 憩室病
  • 潰瘍性大腸炎

第9章：依手術入路分類的切除術市場

  • 微創
    • 腹腔鏡
    • 機器人支援
  • 開放性手術

第10章：依手術類型切除術市場

  • 部分切除術
    • 左半切除術
    • 右半切除術
    • 切除術
    • 橫結腸半切除術
  • 切除術
  • 全切除術

第11章：切除術市場：依最終用戶分類

  • 門診手術中心
  • 醫院外科中心
  • 門診部

第12章：切除術市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：切除術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：切除術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國切除術市場

第16章 中國切除術市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Applied Medical Resources Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Colospan Ltd.
  • CONMED Corporation
  • Cook Group Incorporated
  • CooperSurgical Inc.
  • Fujifilm Holdings Corporation
  • Intuitive Surgical, Inc.
  • Johns Hopkins Medicine
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic PLC
  • NuVasive, Inc.
  • Olympus Corporation
  • SafeHeal SAS
  • Smith & Nephew PLC
  • Stryker Corporation
  • Virtual Incision Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-6A132FD32B20

The Colectomy Procedures Market was valued at USD 1.95 billion in 2025 and is projected to grow to USD 2.05 billion in 2026, with a CAGR of 5.57%, reaching USD 2.86 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.95 billion
Estimated Year [2026] USD 2.05 billion
Forecast Year [2032] USD 2.86 billion
CAGR (%) 5.57%

An authoritative orientation to current developments in colectomy care that bridges clinical practice evolution, technology adoption, and institutional decision-making dynamics

This executive summary introduces a comprehensive examination of colectomy procedures, synthesizing clinical trends, procedural evolution, and stakeholder dynamics that shape practice and procurement across care settings. The analysis centers on how advances in surgical technique, perioperative care pathways, and device innovation intersect with provider workflows and patient expectations to influence decision-making at the clinician and organizational level.

The objective is to provide a succinct yet systematic narrative that helps clinical leaders, hospital administrators, device innovators, and policy stakeholders navigate an increasingly complex landscape. Through evidence-informed observations and cross-disciplinary interpretation, the summary highlights points of inflection where clinical practice and industry strategy converge, framing actionable implications without prescriptive recommendations that require institution-level validation.

Readers will find an integrated perspective that connects clinical indications and procedural approaches to end-user environments and regional dynamics. This introduction sets the stage for deeper sections that analyze transformative shifts, tariff-related impacts, segmentation-derived insights, regional variation, company-level dynamics, recommended actions, and the methodology underpinning the findings.

Key inflection points in colectomy care driven by the convergence of minimally invasive technologies, operational redesign, and evolving outcome-focused clinical practice

The landscape of colectomy procedures is undergoing transformative shifts driven by technological refinement, evolving clinical guidelines, and a growing emphasis on value-based outcomes. Minimally invasive approaches have continued to expand their clinical footprint, not only because of improvements in instrumentation and visualization but also due to deeper integration of perioperative pathways that emphasize early recovery and reduced resource utilization. Alongside this clinical momentum, robotic assistance has matured from niche application to a prominent option for selected complex resections, prompting reassessment of training curricula and capital planning.

Concurrently, patient expectations and payer frameworks are reshaping how care is delivered. Enhanced recovery protocols, outpatient-facing pathways, and same-day surgery feasibility are prompting institutions to redesign admission, discharge, and follow-up processes to optimize throughput while maintaining safety. These operational shifts are aligned with efforts to measure outcomes that matter to patients, including functional recovery and quality-of-life metrics, which in turn influence procedural selection and device adoption.

Finally, the interplay between technological innovation and workforce readiness is redefining competency models for colorectal surgery. Simulation, modular credentialing, and multidisciplinary team integration are emerging as practical enablers for safely expanding minimally invasive and robotic programs. This confluence of clinical, operational, and educational trends marks a departure from incremental change toward coordinated transformation across the care continuum.

How recent tariff adjustments in the United States are reshaping procurement strategies, supply chain resilience, and vendor relationships for colectomy-related technologies

In the United States, recent tariff policy adjustments have introduced an additional layer of complexity for stakeholders involved in procuring surgical instrumentation, robotic platforms, and disposable device components relevant to colectomy procedures. These policy changes have influenced procurement cycles, vendor contracting strategies, and capital planning conversations within hospital systems and ambulatory networks. Institutions with centralized purchasing teams have prioritized contract renegotiation and total-cost-of-ownership evaluations to mitigate the immediate procurement effects while preserving clinical access to preferred technologies.

The cumulative impact has been moderated by several adaptive responses. Clinical teams and supply chain leaders have collaborated more closely to identify clinically equivalent device alternatives, optimize inventory management, and stagger capital acquisition to reduce exposure to tariff-driven price volatility. Additionally, manufacturers and distributors have taken steps to revise commercial terms, localize certain supply chain nodes where feasible, and provide bundled service models that emphasize predictable lifecycle costs and training support.

Looking ahead, sustained tariff-driven pressures are accelerating consideration of regional sourcing strategies and device standardization where clinically appropriate. Stakeholders are balancing the need to maintain advances in minimally invasive and robotic capabilities against the financial imperative to control procedural costs, thereby reinforcing the importance of comprehensive procurement frameworks that align clinical priorities with fiscal stewardship.

Segmentation-driven perspectives that map indications, procedural nuances, surgical approaches, and care settings to practical implications for devices, training, and clinical pathways

Segmentation insights reveal differentiated clinical and commercial pathways across indications, surgical approaches, procedure types, and end-user environments, each carrying distinct implications for technology adoption and care delivery. Based on Indication, market is studied across Cancer, Crohn's Disease, Diverticular Disease, and Ulcerative Colitis, and this distribution informs clinical priorities: oncologic resections demand oncologic principles and lymphadenectomy where applicable, inflammatory bowel disease often requires complex decision-making around preserving bowel length and managing chronic inflammatory changes, while diverticular disease and acute complications emphasize timely source control and complication mitigation.

Based on Surgical Approach, market is studied across Minimally Invasive and Open Surgery. The Minimally Invasive is further studied across Laparoscopic and Robotic Assisted, and these distinctions shape resource needs and training trajectories. Laparoscopic techniques remain foundational for many resections, offering reproducible outcomes with established instrumentation, whereas robotic assistance is leveraged for ergonomic advantages, three-dimensional visualization, and articulated instrument control in anatomically constrained or technically demanding situations. Open surgery retains a vital role for complex emergencies, multi-visceral resections, and scenarios where tactile feedback and rapid exposure are priorities.

Based on Procedure Type, market is studied across Partial Colectomy, Proctocolectomy, and Total Colectomy. The Partial Colectomy is further studied across Left Hemicolectomy, Right Hemicolectomy, Sigmoid Colectomy, and Transverse Hemicolectomy, and this granular typology aligns with variations in operative time, perioperative pathways, and device utilization. Different resection types impose distinct requirements for anastomotic technique, specimen extraction methods, and risk mitigation strategies for complications such as anastomotic leak and postoperative ileus.

Based on End User, market is studied across Ambulatory Surgical Centers, Hospital Surgical Centers, and Outpatient Clinics, and these settings influence workflow design, capital allocation, and care pathway configuration. Ambulatory surgical centers and outpatient clinics are increasingly significant for streamlined procedures and recovery-focused pathways, while hospital surgical centers remain central for complex resections, thoracoabdominal approaches, and high-acuity perioperative management. Understanding these segmentation layers enables stakeholders to tailor training, device bundles, and service models to the clinical and operational realities of each setting.

A comparative regional analysis of practice evolution, capacity expansion, and procurement dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics exert tangible influence on clinical practice models, reimbursement frameworks, and the logistics of device deployment, yielding distinctive patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, integrated health systems and a competitive private sector have driven investment in minimally invasive and robotic capacities, coupled with attention to perioperative efficiency and patient experience. Providers in this region frequently engage in centralized purchasing discussions and value-based pilot programs that shape device selection and service contracting models.

Europe, Middle East & Africa presents a heterogeneous picture where national health system structures, regulatory environments, and workforce distribution result in varied adoption rates. In many countries within this broad region, constrained capital allocation and differing reimbursement incentives emphasize cost-effectiveness and regional centers of excellence. Policymakers and providers often focus on standardizing perioperative care bundles to ensure consistent outcomes across diverse health settings.

Asia-Pacific exhibits rapid capacity expansion in tertiary centers and growing interest in advanced surgical platforms, driven by demographic trends and investment in specialized training. This region balances aggressive technology adoption in urban centers with pragmatic pathways to scale minimally invasive techniques in community hospitals. Across all regions, cross-border collaboration, international training programs, and remote proctoring are facilitating skill transfer and helping harmonize clinical standards despite differing local constraints.

How competitive differentiation, integrated service offerings, and evidence-focused commercial models are redefining company strategies across the colectomy procedural ecosystem

Company-level dynamics within the colectomy ecosystem reveal a competitive environment shaped by product differentiation, service models, and partnership strategies. Leading device manufacturers are prioritizing systems integration, evidence generation, and surgeon-focused support to differentiate their offerings. This includes investments in modular instrumentation, single-use options optimized for workflow, and digital capabilities that support perioperative planning and outcome tracking.

Commercial strategies increasingly emphasize bundled solutions that combine hardware, disposables, training, and service commitments to reduce friction in adoption decisions. Manufacturers and distributors are also experimenting with outcomes-linked contracting and training-as-a-service models to demonstrate value beyond unit sales. Collaborative arrangements between technology providers and clinical centers support iterative product refinement and generate real-world evidence that informs clinical guidelines and payer conversations.

Finally, new entrants and niche innovators are focusing on unmet procedural pain points such as ergonomic enhancements, cost-effective disposable technologies, and tools that streamline anastomosis or specimen extraction. These focused innovations complement broader platform strategies and create pathways for targeted partnerships or licensing arrangements with established players to accelerate market access and clinical validation.

Actionable strategic moves for providers and industry stakeholders to accelerate safe adoption, control costs, and align clinical outcomes with commercial frameworks

Industry leaders can translate the observed trends into concrete initiatives that align clinical quality with operational and commercial objectives. First, prioritize investment in clinician training programs that accelerate safe adoption of minimally invasive and robotic-assisted techniques while embedding enhanced recovery principles to improve throughput and patient outcomes. Structured proctoring, simulation, and competency-based credentialing will reduce variability and enable predictable program expansion.

Second, strengthen cross-functional alignment between clinical leadership and supply chain teams to implement total-cost-of-care evaluations when selecting devices and platforms. Negotiated service-level agreements, transparent lifecycle costing, and clinically informed standardization can preserve access to advanced technologies while containing procedural expenditure. Third, explore flexible commercial arrangements with technology providers, such as bundled procurement, subscription models for instrumentation, and outcomes-linked contracts, to align incentives across stakeholders and reduce capital barriers to adoption.

Finally, accelerate data-driven quality programs that tie procedural choices to patient-reported outcomes and complication metrics. Investing in interoperable data capture and analytics enables continuous improvement, supports payer conversations, and differentiates centers of excellence. These pragmatic steps will help institutions balance clinical innovation with fiscal responsibility and position organizations to respond adaptively to ongoing market and policy shifts.

A mixed-methods research framework integrating clinical evidence, stakeholder interviews, and device performance insights to ensure balanced, practice-oriented conclusions

The research underpinning this executive summary synthesizes peer-reviewed clinical literature, guideline statements, procedural registries, device technical documentation, and interviews with clinical and supply chain leaders across multiple regions. A mixed-methods approach combined qualitative interviews with thematic analysis to surface practical barriers and enablers, while structured reviews of clinical evidence and device characteristics provided technical context for procedural and training implications.

Primary inputs included consultations with practicing colorectal and general surgeons, perioperative nursing leaders, surgical program directors, and hospital procurement professionals. These engagements were used to validate observations about workflow, training needs, device preferences, and the operational impacts of tariff policy adjustments. Secondary sources comprised guideline summaries, published comparative effectiveness assessments, and device labeling and performance specifications to ensure clinical fidelity.

Synthesis prioritized triangulation across evidence streams, favoring consistency of observation and corroboration by multiple stakeholder types. Where perspectives diverged, the analysis highlighted conditional factors and contextual drivers rather than asserting universal conclusions. This methodology ensures that the findings are grounded in clinical practice realities while transparently reflecting areas that require institution-level interpretation.

Synthesis of clinical, operational, and commercial imperatives that define strategic priorities for institutions navigating the evolving colectomy landscape

In conclusion, colectomy procedures are at a strategic crossroads where clinical innovation, operational redesign, and commercial dynamics intersect to create both opportunities and challenges for providers and industry partners. Minimally invasive and robotic-assisted techniques continue to advance clinical capability, while market and policy pressures underscore the importance of procurement agility and cost-conscious adoption strategies. The interplay of indication-specific requirements, procedural heterogeneity, and end-user environments necessitates tailored approaches that respect clinical nuance while enabling scalable implementation.

Organizations that invest in competency-based training, cross-functional procurement frameworks, and data-enabled quality programs will be best positioned to reconcile clinical aspirations with economic realities. Moreover, regional differences in capacity and reimbursement call for differentiated market and operational strategies that reflect local constraints and growth trajectories. Ultimately, success will hinge on collaborative models that align clinician priorities, supply chain rigor, and vendor commitments to deliver predictable patient outcomes and sustainable programmatic growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Colectomy Procedures Market, by Indication

  • 8.1. Cancer
  • 8.2. Crohn's Disease
  • 8.3. Diverticular Disease
  • 8.4. Ulcerative Colitis

9. Colectomy Procedures Market, by Surgical Approach

  • 9.1. Minimally Invasive
    • 9.1.1. Laparoscopic
    • 9.1.2. Robotic Assisted
  • 9.2. Open Surgery

10. Colectomy Procedures Market, by Procedure Type

  • 10.1. Partial Colectomy
    • 10.1.1. Left Hemicolectomy
    • 10.1.2. Right Hemicolectomy
    • 10.1.3. Sigmoid Colectomy
    • 10.1.4. Transverse Hemicolectomy
  • 10.2. Proctocolectomy
  • 10.3. Total Colectomy

11. Colectomy Procedures Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospital Surgical Centers
  • 11.3. Outpatient Clinics

12. Colectomy Procedures Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Colectomy Procedures Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Colectomy Procedures Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Colectomy Procedures Market

16. China Colectomy Procedures Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Applied Medical Resources Corporation
  • 17.7. B. Braun SE
  • 17.8. Baxter International Inc.
  • 17.9. Boston Scientific Corporation
  • 17.10. Cardinal Health Inc.
  • 17.11. Colospan Ltd.
  • 17.12. CONMED Corporation
  • 17.13. Cook Group Incorporated
  • 17.14. CooperSurgical Inc.
  • 17.15. Fujifilm Holdings Corporation
  • 17.16. Intuitive Surgical, Inc.
  • 17.17. Johns Hopkins Medicine
  • 17.18. Johnson & Johnson Services, Inc.
  • 17.19. Karl Storz SE & Co. KG
  • 17.20. Medtronic PLC
  • 17.21. NuVasive, Inc.
  • 17.22. Olympus Corporation
  • 17.23. SafeHeal SAS
  • 17.24. Smith & Nephew PLC
  • 17.25. Stryker Corporation
  • 17.26. Virtual Incision Corporation
  • 17.27. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COLECTOMY PROCEDURES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COLECTOMY PROCEDURES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY CROHN'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY DIVERTICULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ULCERATIVE COLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY LEFT HEMICOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY RIGHT HEMICOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY SIGMOID COLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TRANSVERSE HEMICOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY PROCTOCOLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY TOTAL COLECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY HOSPITAL SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 130. GCC COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 131. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 133. GCC COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 151. G7 COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 152. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 154. G7 COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 158. NATO COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 159. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 161. NATO COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL COLECTOMY PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA COLECTOMY PROCEDURES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY PARTIAL COLECTOMY, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA COLECTOMY PROCEDURES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)